ATE141325T1 - Rekombinantes plasmid, umfassend ein fragment eines dna-segmentes, das für ein 47 kda oberflächenimmunogen von treponema pallidum kodiert - Google Patents
Rekombinantes plasmid, umfassend ein fragment eines dna-segmentes, das für ein 47 kda oberflächenimmunogen von treponema pallidum kodiertInfo
- Publication number
- ATE141325T1 ATE141325T1 AT87906542T AT87906542T ATE141325T1 AT E141325 T1 ATE141325 T1 AT E141325T1 AT 87906542 T AT87906542 T AT 87906542T AT 87906542 T AT87906542 T AT 87906542T AT E141325 T1 ATE141325 T1 AT E141325T1
- Authority
- AT
- Austria
- Prior art keywords
- pallidum
- clones
- immunogen
- recombinant
- kda
- Prior art date
Links
- 241000589884 Treponema pallidum Species 0.000 title abstract 6
- 230000002163 immunogen Effects 0.000 title abstract 5
- 239000013612 plasmid Substances 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title 1
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract 4
- 108020004414 DNA Proteins 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 238000002105 Southern blotting Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000012742 biochemical analysis Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 230000037230 mobility Effects 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000003156 radioimmunoprecipitation Methods 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000002865 vaccinogenic effect Effects 0.000 abstract 1
- 238000001262 western blot Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/913,724 US4868118A (en) | 1986-09-30 | 1986-09-30 | Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE141325T1 true ATE141325T1 (de) | 1996-08-15 |
Family
ID=25433526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87906542T ATE141325T1 (de) | 1986-09-30 | 1987-09-21 | Rekombinantes plasmid, umfassend ein fragment eines dna-segmentes, das für ein 47 kda oberflächenimmunogen von treponema pallidum kodiert |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4868118A (enExample) |
| EP (1) | EP0324774B1 (enExample) |
| JP (1) | JPH02500403A (enExample) |
| AT (1) | ATE141325T1 (enExample) |
| AU (1) | AU8021487A (enExample) |
| CA (1) | CA1336692C (enExample) |
| CH (1) | CH676606A5 (enExample) |
| DE (1) | DE3751870T2 (enExample) |
| DK (1) | DK293988A (enExample) |
| IL (1) | IL84006A (enExample) |
| WO (1) | WO1988002403A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681934A (en) * | 1986-09-30 | 1997-10-28 | Board Of Regents, The University Of Texas System | 47-kilodalton antigen of Treponema pallidum |
| US4956230A (en) * | 1987-04-13 | 1990-09-11 | Minnesota Mining And Manufacturing Company | Ink receptive transparency sheet |
| WO1990015132A2 (en) * | 1989-05-24 | 1990-12-13 | Syntro Corporation | Cloned treponema hyodysenteriae endoflagellar antigen |
| US5474900A (en) * | 1990-03-16 | 1995-12-12 | Sekisui Chemical Co., Ltd. | Process for preparing purified syphilis antigen from Treponema palljdum |
| FR2707168B1 (fr) * | 1993-07-08 | 1995-08-18 | Rhone Merieux | Vaccin contre la dysenterie hémorragique du porc et ensemble de vaccination y relatif. |
| RU2103362C1 (ru) * | 1995-07-14 | 1998-01-27 | Товарищество с ограниченной ответственностью Биотехнологическая компания "БИОСЕРВИС" | Набор для обнаружения антител к бледной спирохете treponema pallidum, рекомбинантный полипептидный антиген treponema pallidum 15 кда, рекомбинантный полипептидный антиген treponema pallidum 17 кда и рекомбинантный полипептидный антиген treponema pallidum tmp a |
| DE19536166C1 (de) * | 1995-09-29 | 1997-03-06 | Siegfried Dr Krell | Verfahren zur Bestimmung von Antikörpern gegen Treponema pallidum (Syphilis) |
| US6020128A (en) * | 1997-06-10 | 2000-02-01 | United States Of Ameria | DNA polymerase from Treponema pallidum |
| WO1999053099A1 (en) * | 1998-04-10 | 1999-10-21 | University Of Washington | Recombinant proteins of treponema pallidum and their use for a syphilis vaccine |
| US6667038B1 (en) * | 1999-04-21 | 2003-12-23 | Boston Medical Center Corp. | Prevention, diagnosis and treatment of lyme disease |
| CA2794710C (en) | 2010-03-31 | 2018-05-08 | Sekisui Medical Co., Ltd. | Reagent for assaying anti-treponema pallidum antibody |
| JP5911889B2 (ja) | 2011-01-13 | 2016-04-27 | オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッドＯｒｔｈｏ−Ｃｌｉｎｉｃａｌ Ｄｉａｇｎｏｓｔｉｃｓ， Ｉｎｃ． | 梅毒トレポネーマトリプレット抗原 |
| CN112772552B (zh) * | 2020-12-31 | 2022-05-17 | 青岛胶南康大饲料有限公司 | 肉兔饲养方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE427516B (sv) * | 1981-11-10 | 1983-04-11 | Ericsson Telefon Ab L M | Sett och anordning for att korrigera distortion i en pa elektronisk veg upptecknad av bildelement lengs linjer uppbyggd bild |
| US4514498A (en) * | 1982-05-26 | 1985-04-30 | The Board Of Regents, The University Of Texas System | Hybrid cell lines producing monoclonal antibodies directed against Treponema |
| JPS59502131A (ja) * | 1982-11-12 | 1984-12-27 | ザ リ−ジエンツ オブ ユニバ−シテイ オブ カリフオルニア | 組換えｄｎａ誘導型梅毒トレポネ−マ抗原 |
-
1986
- 1986-09-30 US US06/913,724 patent/US4868118A/en not_active Expired - Lifetime
-
1987
- 1987-09-21 WO PCT/US1987/002403 patent/WO1988002403A1/en not_active Ceased
- 1987-09-21 EP EP87906542A patent/EP0324774B1/en not_active Expired - Lifetime
- 1987-09-21 AU AU80214/87A patent/AU8021487A/en not_active Abandoned
- 1987-09-21 DE DE3751870T patent/DE3751870T2/de not_active Expired - Lifetime
- 1987-09-21 JP JP62505911A patent/JPH02500403A/ja active Pending
- 1987-09-21 AT AT87906542T patent/ATE141325T1/de not_active IP Right Cessation
- 1987-09-21 CH CH2160/88A patent/CH676606A5/de not_active IP Right Cessation
- 1987-09-23 CA CA000547633A patent/CA1336692C/en not_active Expired - Lifetime
- 1987-09-27 IL IL84006A patent/IL84006A/xx not_active IP Right Cessation
-
1988
- 1988-05-30 DK DK293988A patent/DK293988A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US4868118A (en) | 1989-09-19 |
| JPH02500403A (ja) | 1990-02-15 |
| EP0324774A1 (en) | 1989-07-26 |
| CA1336692C (en) | 1995-08-15 |
| AU8021487A (en) | 1988-04-21 |
| WO1988002403A1 (en) | 1988-04-07 |
| DK293988D0 (da) | 1988-05-30 |
| CH676606A5 (enExample) | 1991-02-15 |
| DK293988A (da) | 1988-07-14 |
| IL84006A0 (en) | 1988-02-29 |
| IL84006A (en) | 1992-11-15 |
| EP0324774B1 (en) | 1996-08-14 |
| DE3751870D1 (de) | 1996-09-19 |
| DE3751870T2 (de) | 1997-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Seco-Mediavilla et al. | Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis | |
| ATE141325T1 (de) | Rekombinantes plasmid, umfassend ein fragment eines dna-segmentes, das für ein 47 kda oberflächenimmunogen von treponema pallidum kodiert | |
| Raoult et al. | Line blot and western blot immunoassays for diagnosis of Mediterranean spotted fever | |
| Nopparatana et al. | Purification of Gnathostoma spinigerum specific antigen and immunodiagnosis of human gnathostomiasis | |
| BR9809443A (pt) | Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão. | |
| Pietkiewicz et al. | Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis | |
| Garin-Bastuji et al. | Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting analysis of smooth-lipopolysaccharide heterogeneity among Brucella biovars related to A and M specificities | |
| Cerar et al. | Humoral immune responses in patients with Lyme neuroborreliosis | |
| Chang et al. | Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay | |
| Sarli et al. | Development and evaluation of a double-antigen sandwich ELISA to identify Anaplasma marginale–infected and A. centrale–vaccinated cattle | |
| Ortiz et al. | Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in serodiagnosis of paracoccidioidomycosis | |
| Ferrara et al. | Characterization of recombinant Ybgf protein for the detection of Coxiella antibodies in ruminants | |
| Nielsen et al. | Validation of a second generation competitive enzyme immunoassay (CELISA) for the diagnosis of brucellosis in various species of domestic animals | |
| US6902903B1 (en) | Helicobacter pylori diagnostics | |
| Pedersen et al. | Specificity of immunoglobulins synthesized within the central nervous system in neurosyphilis | |
| Okada et al. | Serological diagnosis of enzootic pneumonia of swine by a double-sandwich enzyme-linked immunosorbent assay using a monoclonal antibody and recombinant antigen (P46) of Mycoplasma hyopneumoniae | |
| Gilmore Jr et al. | The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early Lyme disease is the flaA gene product | |
| Fulton et al. | Classical immunoproteomics: serological proteome analysis (SERPA) for antigen identification | |
| Bonhomme et al. | Serological microarray for a paradoxical diagnostic of Whipple’s disease | |
| Zhu et al. | Identification of a Coccidioides immitis antigen 2 domain that expresses B-cell-reactive epitopes | |
| Van Vooren et al. | Humoral immune response of tuberculous patients against the three components of the Mycobacterium bovis BCG 85 complex separated by isoelectric focusing | |
| Smith et al. | Structural and antigenic characteristics of Streptococcus sobrinus glucan binding proteins | |
| Attallah et al. | Use of a novel enzyme immunoassay based on detection of circulating antigen in serum for diagnosis of Helicobacter pylori infection | |
| Cunha et al. | Conformational dependence and conservation of an immunodominant epitope within the Babesia equi erythrocyte-stage surface protein equi merozoite antigen 1 | |
| Maeda et al. | Development of an equine herpesvirus type 4-specific enzyme-linked immunosorbent assay using a B-cell epitope as an antigen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |